Therapeutic Guidelines

Care of HIV Positive Pregnant Women and Interventions to Reduce Perinatal Transmission Guidelines

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Supportive non-directive counseling regarding reproductive choices, high risk prenatal care, modified management of labour and delivery, and postpartum

Care of HIV Positive Pregnant Women and Interventions to Reduce Perinatal Transmission Guidelines Read More »

Provincial Best Practice in HIV Case Management

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections Opportunistic Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Provincial Best Practice in HIV Case Management Care of HIV Positive Pregnant Women and Interventions to

Provincial Best Practice in HIV Case Management Read More »

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (HIV PEP) Pre-Exposure Prophylaxis (HIV PrEP) for the prevention of HIV acquisition in British Columbia What’s New in the Guidance for the Use of Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Acquisition in British Columbia (BC)

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia Read More »

HIV Post-Exposure Prophylaxis (PEP) Guidelines

By

Therapeutic Guidelines Menu About COVID-19 Primary Care Guidelines Adults Pediatric Management of Acute HIV Infections HIV Post-Exposure Prophylaxis (PEP) Guidelines Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia For information on how to obtain medication for prevention of HIV infection following a high risk occupational or

HIV Post-Exposure Prophylaxis (PEP) Guidelines Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search